Issue - meetings

To consider a report of the Director of Public Health.

The Pharmaceutical Needs Assessment (PNA) looks at the current provision of pharmaceutical services across Stockport’s Health and Wellbeing Board (HWB) area, assesses whether this meets the current needs of the population and identifies any potential gaps to service delivery. The report provides the Health & Wellbeing Board with an opportunity to discuss and comment on Stockport PNA 2022 document, examine the consultation process and approve the report for publication.

The Board is asked to comment on and approve the report for publication.

Officer contact: Eleanor Banister on 0161 474 2447 or email: eleanor.banister@stockport.gov.uk

The Director of Public Health submitted a report (copies of which had been circulated) providing the Pharmaceutical Needs Assessment (PNA) which outlined the current provision of pharmaceutical services across Stockport’s Health and Wellbeing Board (HWB) area, assessed whether this met the current needs of the population and identified any potential gaps to service delivery. The report provided the Health & Wellbeing Board with an opportunity to discuss and comment on Stockport PNA 2022 document, examine the consultation process and approve the report for publication.

The following comments were made/issues raised: -

·         Welcomed the report and thanked officers for their work to produce a comprehensive, high quality and well considered report.

·         Requested additional information in relation to the New Medicines Service.

·         In response it was commented that the service was available from both community pharmacies and internet/distance selling pharmacies and was provided when a patient starts a medicine for the first time. The pharmacist would go through with the patient what the medicine is used for, how you take it and in particular any interactions for them.

·         Noted the New Medicines Service and acknowledged the value that it provided for residents.

RESOLVED – (1) That the report be noted.

(2) That the Stockport Pharmaceutical Needs Assessment be agreed and recommended for publication.